文献速递先天性心脏病外科

唐氏综合征患儿Fontan术后死亡率显著改善

Significant Improvements in Mortality After the Fontan Operation in Children With Down Syndrome.
PubMed 文献 · Ann Thorac Surg · 2019-09-13

基于STS先天性心脏病数据库的16年回顾性研究(2001-2016,共12,074例)显示,Fontan手术总体院内死亡率从2.4%降至1.3%(P<.001)。唐氏综合征组院内死亡率仍显著高于非唐氏组(12.3% vs 1.6%,P<.001),多变量分析中唐氏综合征是院内死亡的最强预测因子(OR 11.6,95%CI 5.1-26.4)。

要点

  • Fontan术后总体院内死亡率近期显著改善至1.3%
  • 唐氏综合征组院内死亡率12.3%,仍显著高于非唐氏组1.6%
  • 唐氏综合征是院内死亡最强预测因子,校正OR 11.6

核心结论

  • 当代Fontan手术院内死亡率显著改善,但唐氏综合征仍是院内死亡和并发症的重要危险因素。

研究设计与样本

  • 回顾性研究,使用STS先天性心脏病数据库,纳入2001-2016年接受Fontan手术的功能性单心室患者共12,074例(唐氏81例,非唐氏11,993例)。
  • 主要结局为院内死亡率,采用单变量和多变量logistic回归分析预测因素。

主要发现

  • 总体院内死亡率在近期(2009-2016)显著改善:2.4%至1.3%,P<.001。
  • 唐氏组院内死亡率高于非唐氏组(12.3% vs 1.6%,P<.001),OR 8.6(95%CI 4.4-17.0)。
  • 唐氏组30天死亡率更高、术后中位住院时间更长、术后并发症发生率更高。
  • 多变量模型显示唐氏综合征是院内死亡最强预测因子,OR 11.6(95%CI 5.1-26.4),校正时代效应、体重和主要心脏诊断等变量。

临床怎么用

  • 唐氏综合征患儿行Fontan手术前应充分评估死亡风险,术后加强监护和并发症管理。
  • 近期Fontan手术整体预后改善,但唐氏综合征仍是高风险人群,需个体化决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Down syndrome (DS) is considered a risk factor for mortality associated with the Fontan operation. The objective was to show the contemporary short-term outcome of the Fontan operation for a functionally univentricular heart in patients with DS and non-DS, along with an analysis of significant predictors for in-hospital mortality. METHODS: This was a retrospective study using The Society of Thoracic Surgeons Congenital Database to assess in-hospital mortality and its predictors in patients with DS and non-DS undergoing the Fontan operation over 16 years (2001-2016). The primary outcome was in-hospital mortality. Statistical analysis was performed using univariable and multivariable logistic regression models. RESULTS: Our study cohort consisted of 12,074 patients (81 DS and 11,993 non-DS). The overall in-hospital mortality rate significantly improved in the recent era (2009-2016): 2.4% to 1.3%, P < .001. The DS group had a higher in-hospital mortality rate (12.3% vs 1.6%, P < .001) with an odds ratio of 8.6 (95% confidence interval, 4.4-17.0). The DS group had a higher 30-day mortality rate, a longer median postoperative length of stay, and a higher incidence of postoperative complications. The multivariable model showed that DS was the strongest predictor of in-hospital mortality, with an odds ratio of 11.6 (95% confidence interval, 5.1-26.4), adjusted for other significant variables including era effect, weight, and primary cardiac diagnosis. CONCLUSIONS: The in-hospital mortality for the Fontan operation significantly improved in the contemporary era. DS was a significant risk factor for in-hospital morbidity and mortality associated with the Fontan operation.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Sarno LA, Walters HL, Bondarenko I, et al. Significant Improvements in Mortality After the Fontan Operation in Children With Down Syndrome. Ann Thorac Surg. 2019. PMID: 31525348. doi:10.1016/j.athoracsur.2019.07.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。